Anthocyanins can prevent and ameliorate type 2 diabetes
mellitus
(T2DM), but its mechanism of action has not been fully established.
IKK/NF-κB and JAK/Stat pathways have multiple effects, triggering
T2DM. Liver abnormalities in individuals with T2DM are detrimental
to glycemic control. We determined whether anthocyanins could improve
the liver of individuals with T2DM using IKK/NF-κB and JAK/Stat.
We established a T2DM mouse model using a high-fat diet and streptozotocin
and then performed Aronia melanocarpa anthocyanin extracts’ (AMAEs’) administration for
5 weeks. AMAEs improved blood glucose and hyperinsulinemia of T2DM
mice. In the liver of AMAE-administered T2DM mice, ROS, IKKβ/NF-κB
p65, and JAK2/Stat3/5B signalings were down-regulated, thereby reducing
the suppressor of cytokine signaling 3 (SOCS3), iNOS, and inflammatory
mediators. AMAE-improved hyperinsulinemia also down-regulated SOCS3
by decreasing p-Stat5B in hepatocytes. AMAEs enhanced glucose uptake
and conversion and decreased hepatocyte enlargement and inflammatory
cells in the liver of T2DM mice. These indicated that AMAEs could
alleviate oxidative stress, insulin resistance, inflammation, and
tissue damage in the liver of T2DM mice through inhibiting NF-κB
p65 and Stat3/5B.